Apolipoprotein E polymorphism and acute ischemic stroke: A diffusion- and perfusion-weighted magnetic resonance imaging study

Journal of Cerebral Blood Flow and Metabolism

Volumn 22, Issue 11, 2002, Pages 1336-1342

  Liu, Yawu ^a   Laakso, Mikko P ^a   Karonen, Jari O ^a   Vanninen, Ritva L ^a   Nuutinen, Juho ^a   Soimakallio, Seppo ^a   Aronen, Hannu J ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Apolipoprotein E; Genetics; Imaging; Magnetic resonance; Outcome; Stroke

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ARTICLE; BRAIN BLOOD VOLUME; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CORRELATION ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STROKE;

EID: 0036843889     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.WCB.0000033200.58646.B3     Document Type: Article

References (24)

1. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. (1993) Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial. Stroke 24:35-41
2. Alberts MJ, Graffagnino C, McClenny C, et al. (1995) ApoE genotype and survival from intracerebral hemorrhage. Lancet 346:575
3. Baird AE, Dambrosia J, Janket S-J, et al. (2001) A three-item scale for the early prediction of stroke recovery. Lancet 357:2095-2099
4. Basun H, Corder EH, Guo Z, et al. (1996) Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. Stroke 27:1310-1315
5. Beaulieu C, de Crespigny A, Tong DC, Moseley ME, Albers GW, Marks MP (1999) Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: Evolution of lesion volume and correlation with clinical outcome. Ann Neurol 46:568-578
6. Brott T, Adams HP Jr, Olinger CP, et al. (1989) Measurements of acute cerebral infarction: A clinical examination scale. Stroke 20:864-870
7. Helisalmi S, Linnaranta K, Lehtovirta M, et al. (1996) Apolipoprotein E polymorphism in patients with different neurodegenerative disorders. Neurosci Lett 205:61-64
8. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545-548
9. Horsburgh K, Kelly S, McCulloch J, Higgins GA, Roses AD, Nicoll JAR (1999) Increased neuronal damage in apolipoprotein Edeficient mice following global ischemia. NeuroReport 10:837-841
10. Kluytmans M, van Everdingen KJ, Kappelle LJ, Ramos LMP, Viergever MA, van der Ground J (2000) Prognostic value of perfusion and diffusion-weighted MR imaging in first 3 days of stroke. Eur Radiol 10:1434-1441
11. Laskowitz DT, Sheng H, Bart RD, Joyner KA, Roses AD, Warner DS (1997) Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia. J Cereb Blood Flow Metab 17:753-758
12. Lehtovirta M, Laakso MP, Frisoni GB, Soininen H (2000) How does the apolipoprotein E genotype modulate the brain in aging and Alzheimer's disease? A review of neuroimaging studies. Neurobiol Aging 21:293-300
13. Lövblad K-O, Baird AE, Schlaug G, et al. (1997) Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol 42:164-170
14. Mahley RW, Rall SC Jr (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1:507-537
15. McCarron MO, Muir KW, Nicoll JAR, et al. (2000) Prospective study of apolipoprotein E genotype and functional outcome following ischemic stroke. Arch Neurol 57:1480-1484
16. Østergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR (1996a) High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn Reson Med 36:715-725
17. Østergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR (1996b) High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magn Reson Med 36:726-736
18. Sheng H, Laskowitz DT, Bennett E, et al. (1998) Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice. J Cereb Blood Flow Metab 18:361-366
19. Sheng H, Laskowitz DT, Mackensen GB, Kudo M, Pearlstein RD, Warner DS (1999) Apolipoprotein E deficiency worsens outcome from global cerebral ischemia in the mouse. Stroke 30:1118-1124
20. Slooter AJC, Tang M-X, van Duijn CM, et al. (1997) Apolipoprotein E ε4 and risk of dementia with stroke: A population-based investigation. JAMA 227:818-821
21. Teasdale GM, Nicoll JA, Murray G, Fiddes M (1997) Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 350:1069-1071
22. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604-607
23. Warach S, Pettigrew LC, Dashe JF, et al. (2000) Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 48:713-722
24. Weir CJ, McCarron MO, Muir KW, et al. (2001) Apolipoprotein E genotype, coagulation, and survival following acute stroke. Neurology 57:1097-1100